Wordt geladen...
AGR2 Predicts Tamoxifen Resistance in Postmenopausal Breast Cancer Patients
Endocrine resistance is a significant problem in breast cancer treatment. Thus identification and validation of novel resistance determinants is important to improve treatment efficacy and patient outcome. In our work, AGR2 expression was determined by qRT-PCR in Tru-Cut needle biopsies from tamoxif...
Bewaard in:
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Hindawi Publishing Corporation
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3776368/ https://ncbi.nlm.nih.gov/pubmed/24167368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/761537 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|